NORTHERN TRUST CORP - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 26 filers reported holding BIOCEPT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2023$9,118
-35.9%
26,8180.0%0.00%
Q4 2022$14,214
-43.1%
26,8180.0%0.00%
Q3 2022$25,0000.0%26,8180.0%0.00%
Q2 2022$25,000
-60.3%
26,818
-2.1%
0.00%
Q1 2022$63,000
-36.4%
27,393
+0.3%
0.00%
Q4 2021$99,000
-10.0%
27,3180.0%0.00%
Q3 2021$110,000
-6.8%
27,318
-2.6%
0.00%
Q2 2021$118,000
-17.5%
28,0470.0%0.00%
Q1 2021$143,000
+22.2%
28,047
+6.0%
0.00%
Q4 2020$117,000
-4.1%
26,459
-4.4%
0.00%
Q3 2020$122,00027,6630.00%
Other shareholders
BIOCEPT INC shareholders Q4 2022
NameSharesValueWeighting ↓
GLOBEFLEX CAPITAL L P 321,055$1,287,0000.28%
GSA CAPITAL PARTNERS LLP 92,639$371,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 51,967$208,0000.02%
Jump Financial, LLC 19,500$78,0000.01%
MARSHALL WACE, LLP 104,980$421,0000.00%
VANGUARD GROUP INC 658,586$2,640,0000.00%
Focused Wealth Management, Inc 1$00.00%
JANE STREET GROUP, LLC 11,181$45,0000.00%
UBS Group AG 1,984$8,0000.00%
OSAIC HOLDINGS, INC. 7,600$30,0000.00%
View complete list of BIOCEPT INC shareholders